Health

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025 16:30 ET  | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 06, 2025 (GLOBE…

7 months ago

RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress

June 06, 2025 16:07 ET  | Source: Restem MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology…

7 months ago

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

June 05, 2025 18:38 ET  | Source: Xilio Therapeutics, Inc. Total gross proceeds of up to $150.0 million before the…

7 months ago

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

June 05, 2025 17:35 ET  | Source: DENTSPLY SIRONA Inc. CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA…

7 months ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 05, 2025 17:00 ET  | Source: Anika Therapeutics Inc. BEDFORD, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics,…

7 months ago

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference

June 05, 2025 01:00 ET  | Source: Addex Therapeutics Geneva, Switzerland, June 5, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a…

7 months ago

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology

Third asset to advance into clinical trials, validating broad potential of Launch-iT platformAll subjects treated with first dose of AVX70371…

7 months ago

Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG…

7 months ago

Molecular Health and Axxam enter into a strategic partnershipto bolster the discovery of innovative targets in drug development

MILAN, Italy and HEIDELBERG, Germany, June 04, 2025 (GLOBE NEWSWIRE) -- Axxam S.p.A., a premier provider of integrated early discovery…

7 months ago

Philips to repurchase up to 6 million shares to cover long-term incentive plans

June 4, 2025  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase up to 6 million shares to…

7 months ago